 4. Individuals with any disease or condition of the skin e.g., active i.e. flaring eczema or psoriasis, skin cancer, atypical nevus, polymorphic light eruption PMLE, porphyria, systemic lupus erythematous SLE, xeroderma pigmentosa XP that could interfere with the study or increase risk to the subject. 